2. Academic Validation
  3. Role of the APRIL molecule in solid tumors

Role of the APRIL molecule in solid tumors

  • Cytokine Growth Factor Rev. 2021 Oct;61:38-44. doi: 10.1016/j.cytogfr.2021.08.001.
Kinga Henryka Nowacka 1,  Ewa Jabłońska 2
Affiliations

Affiliations

  • 1 Department of Immunology, Medical University of Bialystok, J. Waszyngtona 15A, 15-269 Białystok, Poland. Electronic address: kinga.nowacka@umb.edu.pl.
  • 2 Department of Immunology, Medical University of Bialystok, J. Waszyngtona 15A, 15-269 Białystok, Poland. Electronic address: ewa.jablonska@umb.edu.pl.
PMID: 34446365 DOI: 10.1016/j.cytogfr.2021.08.001
Abstract

The APRIL molecule, produced by immune cells, their precursors, and Cancer cells, is one of the important factors that influences the process of survival and proliferation of Cancer cells. In the present review, we summarize the current knowledge on the effects of APRIL on human Cancer development and develop a scheme demonstrating the mechanism of the action of APRIL on solid tumors. Understanding the effects of APRIL, including the intracellular signal transduction pathway, may be key for the use of this protein as a biomarker of the Cancer process. The correlations observed between APRIL levels and Cancer parameters (e.g., disease stage and presence of malignant phenotypes) indicate that APRIL may play an important role, not only in the diagnostic process, but also as a therapeutic target in various cancers.

Keywords

A Proliferation-inducing ligand; Cancer; TALL-2; TNFSF13.

Figures
Products